Difference between revisions of "Minutes - Medication WG 2022-02-15"

From Health Level 7 Belgium Wiki
Line 48: Line 48:
 
::* ISO IDMP gap analysis on SAM V2 has been done  
 
::* ISO IDMP gap analysis on SAM V2 has been done  
 
::::* ISO IDMP does not present a fixed vocabulary
 
::::* ISO IDMP does not present a fixed vocabulary
−
::::* objective is to map SAMv2 to ISO IDMP database
+
::::* objective is to map SAMv2 to ISO IDMP database, works quite well although there are no identifiers in the 2 sytems
 +
::::* attributes can be useful for the mapping
 +
* How can we query with FHIR on SAMv2 ?
 +
::* f.e. if doctor wants to query on substance
 +
::* what are the logical models behind: see https://www.samportal.be/nl/sam/documentation PIM logical model
 +
* Concept of VMP group: it is a clinical concept
 +
::* to add
 +
* VMP is more a regulatory concept
 +
* our WG goal: how to represent medication in a medication scheme - which recommendation is there ? current MS is focused on brand name, VOS-group of substance seems better from a clinical point of view of VMP-group as it includes the route of administration
 +
::* RIZIV wants a different view so both levels will have to be there (packages)
  
−
* José did not have time to prepare the use cases due to personal circumstances
+
 
−
* upcoming problem of catalog of medicines: there are CNK, CTI, ATC and plenty of other codes, also virtual therapautic group as called in Belgium (FAGG provides the codes) ; VMPP is abandoned in Belgium
+
 
−
::* the codes are at different level and different granularities
+
 
−
::* which codes will we use in the medication scheme ?
+
 
−
::* whatever we want, we depend with what FAGG will provide as this is legal
+
* VIDIS would like to have first artefacts of our WG
−
::* see [https://drive.google.com/file/d/12kAqhFi0FPbJGp2xZ5N4_YgeYq5g--iv/view?usp=sharing scheme here]
+
::* medication treatment line are being worked on
−
::* we have to look at SAM : https://samviewer.digile.be/nl/sam/ampps/250266-13
+
* We have started working on [https://docs.google.com/document/d/1rTGHvdNMZfR4MZvVVIfUnoAi8eDQsYTpcKBB3B8q4JI/edit# a document listing different concepts] that will be used in the medication scheme, how we consist
−
* Looking at while discussing:
 
−
::* https://build.fhir.org/resourcelist.html
 
−
::* https://www.hl7.org/fhir/medication.html
 
−
::* https://www.hl7.org/fhir/medicationknowledge.html
 
−
::* what France is doing: https://simplifier.net/guide/fr-Medication/Ressources2
 
−
::* vmpgroup -> vmp -> amp -> ampp -> cnk
 
−
::* Unicom project: see https://unicom-project.eu/ and [https://unicom-project.eu/wp-content/uploads/2021/10/UNICOM-handboek_A4_04.pdf interesting summary here]
 
−
* Jens will start working on[https://docs.google.com/document/d/1rTGHvdNMZfR4MZvVVIfUnoAi8eDQsYTpcKBB3B8q4JI/edit# a document listing different concepts] that will be used in the medication scheme
 
  
  

Revision as of 11:40, 15 February 2022

Attendees
  • An Crepel, digile
  • Annemieke Vergauwe
  • Bart Decuypere
  • Jan Lenie
  • Jean-Michel Polfliet
  • Jens Penny
  • José Costa Teixeira
  • Karlien Erauw
  • Kris Deceunynck
  • Pablo Christiaens
  • Thomas Van Langendonck
  • Tom Henkens
Excused/Not present
  • Anne Nerenhausen
  • Bruno Casneuf
  • Dieter Sauvillers
  • Elhassan Baazizi
  • Hanne Vuegen
  • Jean-Louis Maggetto
  • Jeroen De Wilde
  • Katrien Thorré
  • Lars Vanreppelen
  • Marc Buckens
  • Nick Hermans
  • Nils Devos
  • Richard Francken
  • Thomas Van Langendonck
  • Tom De Backer
  • Walter Bollaert
  • Will van Norel
Agenda
  • discussion on drug databaes
  • review of prepared use cases
Minutes
  • An from Digile has worked on the SAM database and has plenty of drug data expertise
  • BCFI, the green booklet used by pharmacists & doctors
  • BCFI was structured in a Repertorium drug tables
  • SAM is a consortium: APB, RIZIV, FOD VG, FAGG to put all drugs in one database
  • VMP, VMP-groups are concepts were implemented through guidance from BCFI
  • public SAM viewer was developed by Digile, visualisation in an intuitive manner that has the full SAMv2 content (2 updates a day - not realtime), is public
  • feedback option is available as there are still some data quality issues & inconsistencies with SAM
  • difficult follow-up on raised issues
  • overview of VOs-groups to improve easier access to these data that was not open to the public before
  • ISO IDMP gap analysis on SAM V2 has been done
  • ISO IDMP does not present a fixed vocabulary
  • objective is to map SAMv2 to ISO IDMP database, works quite well although there are no identifiers in the 2 sytems
  • attributes can be useful for the mapping
  • How can we query with FHIR on SAMv2 ?
  • Concept of VMP group: it is a clinical concept
  • to add
  • VMP is more a regulatory concept
  • our WG goal: how to represent medication in a medication scheme - which recommendation is there ? current MS is focused on brand name, VOS-group of substance seems better from a clinical point of view of VMP-group as it includes the route of administration
  • RIZIV wants a different view so both levels will have to be there (packages)



  • VIDIS would like to have first artefacts of our WG
  • medication treatment line are being worked on


Action items for next meeting

  • José to work on use cases and add medication view line in view and how it all works at operational level
  • Jens to start writing up document

Next meeting March 1 at 11AM

Retrieved from "https://wiki.hl7belgium.org/index.php?title=Minutes_-_Medication_WG_2022-02-15&oldid=1438"